title: [Position of Experts Panel of the Polish Gynecological Society in the application of low molecular weight heparin - nadroparin calcium (Fraxiparine) in obstetrics and gynecology].
authors: I Katedra i Klinika Ginekologii Onkologicznej i Ginekologii Uniwersytetu Medycznego w Lublinie.
authors: Wiesława
authors: W
authors: Bednarek
authors: Agata
authors: A
authors: Karowicz-Bilińska
authors: Jan
authors: J
authors: Kotarski
authors: Ewa
authors: E
authors: Nowak-Markwitz
authors: Przemysław
authors: P
authors: Oszukowski
authors: Tomasz
authors: T
authors: Paszkowski
authors: Ryszard
authors: R
authors: Poreba
authors: Marek
authors: M
authors: Spaczyński
authors: Justyna
authors: J
authors: Teliga-Czajkowska
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006176:Gynecology / Q000592:standards; D006801:Humans; D017762:Nadroparin / Q000627:therapeutic use*; D009313:National Health Programs / Q000592:standards; D009774:Obstetrics / Q000592:standards; D011044:Poland; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011785:Quality Assurance, Health Care / Q000592:standards*; D012955:Societies, Medical / Q000592:standards; D054556:Venous Thromboembolism / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D017762:Nadroparin